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Leonardis, and Roglianidoi:10.1016/j.jtcvs.2004.05.024Objective: This study was undertaken to analyze the comprehensive outcome of
unilateral lung volume reduction in patients with distinct heterogeneity of emphy-
sema between lungs assessed by a visual radiologic scoring system.
Methods: Ninety-seven patients who underwent intentional unilateral lung volume
reduction because of distinct heterogeneity of emphysema between lungs (asym-
metric ratio of emphysema 1.1) between 1995 and 2003 were evaluated. Baseline
median measures were 0.83 L for forced expiratory volume in 1 second, 5.0 L for
residual volume, 380 m for 6-minute walking test distance, 0.50 for maximal
incremental treadmill test score, and 25 for physical functioning domain score
assessed by the Short Form-36 Quality of Life questionnaire.
Results: Median follow-up was 34 months. Significant improvements occurred for
as long as 36 months in forced expiratory volume in 1 second (24%), residual
volume (12%), Short Form-36 Quality of Life questionnaire physical functioning
domain score (100%), 6-minute walking test distance (18%), and maximal
incremental treadmill test score (200%). A direct correlation was found between
asymmetric ratio of emphysema and change in forced expiratory volume in 1 second
(r  0.65, P  .00001). At 60 months, residual volume (6.2%), maximal
incremental treadmill test score (100%), and Short Form-36 Quality of Life
questionnaire physical functioning domain score (70%) were still significantly
improved. Five-year survival was 82%; 5-year freedom from contralateral lung
volume reduction was 70%.
Conclusions: In this series, significant, long-lasting improvements and satisfactory
survival were seen after intentional unilateral lung volume reduction. Heterogeneity
of emphysema between lungs was directly correlated with improvement at 36
months in forced expiratory volume in 1 second. Our results suggest that unilateral
lung volume reduction is a suitable option for patients with distinct heterogeneity of
emphysema between lungs.
Lung volume reduction (LVR) has shown to improve subjectivedyspnea, respiratory function, exercise capacity, and quality of lifefor as long as 5 years for selected patients with severe emphyse-ma.1-3 Maximal benefit is achieved when distinct regional differencein tissue destruction (markedly heterogeneous emphysema withinlungs) and upper-lobe predominance of disease is identified by
visual radiologic scoring systems.4
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either unilateral5-8 or bilateral1-3 fashion. Current consensus
is that the best technique is simultaneous bilateral stapling
resection, either through a median sternotomy9 or by video-
assisted thoracoscopic surgery10, because of its superior
incremental benefit relative to the unilateral approach.11
However, Brenner and coworkers12 have reported that de-
terioration in forced expiratory volume in 1 second (FEV1)
after bilateral LVR was steeper than that after unilateral
treatment. Naunheim and colleagues13 have reported similar
3-year survivals after unilateral and bilateral LVR. More
recently, Goldstein and coworkers14 have found no differ-
ence in disease specific quality of life changes between
patients undergoing bilateral and unilateral LVR. Further-
more, in a previous study 15 we found that distinct hetero-
geneity of emphysema between lungs (high asymmetric
ratio of emphysema [ARE]) was a predictor of maximal
improvement in FEV1, with a positive predictive value of
88%. These controversial findings do not call into question
the already defined role of bilateral LVR in patients with
bilateral heterogeneous emphysema. Nonetheless, they do
suggest that the role of unilateral LVR is yet to be defined
and merits further investigation. The aim of this retrospec-
tive, single-cohort study was to analyze the comprehensive
outcome of sole unilateral thoracoscopic LVR performed
intentionally according to precise radiologic morphologic
criteria in a tertiary care university-based referral center.
Patients and Methods
Patients
Our LVR surgery program started in October 1995. Through April
2003, a total of 158 patients underwent unilateral (n  119) or
one-stage bilateral (n  39) thoracoscopic LVR. Among unilater-
ally treated patients, 97 patients undergoing intentional unilateral
LVR because of radiologic evidence of distinct heterogeneity of
emphysema between lungs were evaluated. After unilateral treat-
ment, contralateral LVR was allowed during follow-up when ei-
ther the FEV1 returned to the baseline value or the patient became
dissatisfied with the functional gain. Data from 14 subjects who
underwent staged bilateral LVR were considered in the functional
outcome analysis until the last follow-up that preceded the second
operation. Conversely, the entire follow-up length was considered
for both survival analysis and risk analysis for contralateral treat-
ment.
Patients selected for the operation had emphysema graded radio-
logically as severe and had significant functional disability despite
maximal medical therapy. Eligibility criteria for LVR have been
described previously elsewhere16 and included postbronchodilator
FEV1 less than 40% predicted, residual volume (RV) more than 180%
predicted, and radiologic evidence of severe emphysema with recog-
nizable target areas for resection. Additional requirement for inten-
tional unilateral LVR was radiologic evidence of distinct heterogene-
ity of emphysema between lungs. No patient had isolated giant
bullous emphysema. All patients were former smokers and had quit
smoking at least 4 months before the operation; no patient was
homozygous for 1-antitrypsin deficiency.
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Pulmonary function tests were performed after administration of 2
puffs of aerosolized albuterol (INN salbutamol). Static lung vol-
umes were determined by plethysmography, and diffusing capacity
for carbon monoxide was assessed by the single-breath technique.
Reference spirometric values were those of the European Respi-
ratory Society.17 Exercise tolerance was assessed by standard
6-minute walk test (SMWT) and by maximal incremental treadmill
test (MITT). MITT was performed with stepwise increase of both
velocity (from 2.7 km/h to 6.8 km/h) and gradient (from 0° to 16°)
until the symptom-limited maximum was reached, according to
10-stage modified Bruce protocol. Quality of life was assessed
with the self-administered Medical Outcomes Study 36-Item
Short-Form Health Survey questionnaire (SF-36); the version used
was that validated in Italy.18
The most severely deconditioned patients were encouraged to
undergo a 4-week preoperative rehabilitation program, although
this was not an absolute prerequisite. All baseline tests were
performed during periods of clinical stability or within 1 week
after the completion of a preoperative rehabilitation program.
Complete symptomatic, functional, and quality of life assessments
were repeated 6 and 12 months after the operation and then yearly.
All data were prospectively stored in a database.
Radiologic Assessment
Radiologic morphologic character of emphysema was assessed
according to a previously validated visual scoring system.15
Briefly, with high-resolution computed tomography (CT), six stan-
dard lung scans obtained from lung apex to base at end-inspiration
as reference levels were exactly defined by anatomic structures
(brachiocephalic trunk, aortic arch, main pulmonary artery, middle
lobe bronchus, ventricular chambers, and 1 cm above the dia-
phragm). The following factors were assessed in each lung: (1)
The degree of hyperinflation was expressed by the degree of
impairment in diaphragmatic excursion estimated in centimeters
by superimposing the inspiratory and expiratory posteroanterior
chest radiographs with the spine for registration. (2) The severity
of emphysema was graded in each CT layer by estimating the
percentage of destroyed lung tissue (grade 1 for 0%-25%, grade 2
for 25%-50%, grade 3 for 50%-75%, and grade 4 for 75%). (3)
In each lung, the difference between the median severity of em-
physema score in the three worst sections and the three best
sections was calculated to express the degree of heterogeneity of
disease within the lung. (4) The ARE (difference between the
lungs) was expressed by the ratio of the higher emphysema
severity score to the lower emphysema severity score (Figure 1,
A and B). ARE was also influenced by the regional lung
hyperinflation, which was estimated after exclusion of signifi-
cant scoliosis by measuring the degree of mediastinal switch
from the midline. A deviation of at least 1 cm from the midline
in at least two standard CT layers (Figure 1, C) added a score
of 0.1 to the ARE.
Surgical Strategy and Technique
Patients with ARE of at least 1.1 were selected for intentional
unilateral LVR. The procedure was directed at reducing the lung
volume by excising functionally useless and hyperinflated lung
tissue by means of video-assisted thoracoscopic surgery. In typical
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was performed to excise a reversed U–shaped single strip of
emphysematous lung tissue, reducing the upper lobe of about 60%.
Statistics
Group descriptive statistics are presented as median and interquar-
tile range. The Wilcoxon rank-sum test was used for pair data
because of the nonnormal distribution of some data and the small
sample size at longest follow-up assessments. Frequencies were
compared with a 2 test or Fisher exact test as appropriate. Cor-
relations were assessed with Spearman correlation coefficients.
Survival and risk of contralateral LVR were assessed by the
Figure 1. High-resolution CT scan showing distinct heterogeneity
between lungs because of more severe emphysematous destruc-
tion in right upper lobe. A, Left score of 2, right score of 3. B, Left
score of 1, right score of 1. ARE of 1.33. C, High-resolution CT scan
showing distinct heterogeneity of emphysema between lungs
because of more severe regional hyperinflation in left upper lobe
causing rightward shift (AB1) of mediastinum from midline (AB).Kaplan-Meier method.
The Journal of ThoracResults
There were 95 men and 2 women, with a median age of 65
years. Assessment of radiologic morphologic character of
emphysema is depicted in Table 1. Preoperative rehabilita-
tion was performed by the 13 most deconditioned patients.
The 90-day and complete in-hospital mortality in this series
was 1.03% and included 1 patient who died of respiratory
failure. The median hospital stay was 9 days, with a range
of 4 to 65 days. Median follow-up was 34 months, with no
patients unavailable, and ranged from 24 days for the single
postoperative death to 85 months. Baseline and postopera-
tive measures of the study group are detailed in Table 2.
Oxygen therapy was required at rest or during exercise by
39 patients before the operation and by 26 of 69 patients at
12 months (P  .75).
Changes in Physiologic Variables
The FEV1 and RV showed statistically significant improve-
ments between preoperative values and values at 6, 12, 36,
and 48 months. Only RV remained improved for as long as
60 months. At 3 years, 17 of 40 evaluated patients (42.5%)
had an improvement in FEV1 of at least 0.2 L; no patients
maintained such improvement for at 60 months. Change in
FEV1 at 36 months proved directly correlated with ARE
(Figure 2), whereas no correlation was found with degree of
heterogeneity within the lung (r  .21, P  .07), degree of
hyperinflation (r  .21, P  .18), and severity of emphy-
sema (r  .27, P  .08). Diffusion capacity for carbon
monoxide had not improved either at 6 months or subse-
quently. PaO2 was increased significantly at 6 months and
remained improved for as long as 12 months. PCO2 averaged
40 mm Hg before the operation and had not changed mean-
ingfully as late as 60 months. SMWT and MITT increased
acutely and remained improved for as long as 48 months; at
60 months, only MITT remained significantly improved.
Changes in Quality of Life
Among the eight SF-36 quality of life domains, physical
TABLE 1. Radiologic morphologic character of emphysema
in the study group
Upper lobe/middle-lower lobe emphysema (No.) 95/2
Giant bullae* (No.) —
ARE 1.28 (1.18-1.38)
Patients with ARE 1.2 (No.) 71
Within-lung heterogeneity of disease score 1.0 (1.0-2.0)
Patients with within-lung heterogeneity score
1 (No.)
89
Degree of hyperinflation score 3.0 (2.5-3.0)
Severity of emphysema score 28 (25-33)
Data are expressed as absolute values or as median values with inter-
quartile ranges.
*Bullae 7 cm in maximal size.functioning (PF) score was improved for as long as 60
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 .01), vitality (P  .01), and social functioning (P 
.0002) scores were improved for as long as 48 months; and
role emotional (P .01) and mental health (P .01) scores
were improved for as long as 36 months. Overall, an incre-
ment in PF of at least 10 points, which is considered to be
clinically significant, was seen at 1, 3, and 5 years in 61
patients (88%), 34 patients (83%), and 11 patients (57%),
respectively.
Results in Patients with 5-Year Follow-up
Because longitudinal analysis with a shrinking cohort is
Figure 2. Relationship between ARE and change in FEV1 at 36
months.
TABLE 2. Baseline and postoperative data in the study co
Baseline
(n  97) 6 mo
FEV1 (L) 0.83 (0.69-1.0) 1.13* (
FEV1 (% predicted) 27.5 (24.2-36.8) 40* (
Forced vital capacity (L) 2.50 (2.0-2.8) 3.05* (
Forced vital capacity (% predicted) 67 (57-77) 83* (
RV (L) 5.01 (4.6-5.7) 4.0* (
RV (% predicted) 220 (195-254) 176* (
PaO2 (mm Hg) 69 (65-75) 72* (
SMWT (m) 380 (350-420) 480* (
MITT (Bruce class) 0.50 (0.50-1.0) 2.0* (
SF-36 PF score 25 (15-40) 50* (
Data are expressed as median values with interquartile ranges.
*P  .0002 versus baseline.
†P  .003 versus baseline.
‡P  .01 versus baseline.prone to bias, we separately analyzed the results achieved in
76 The Journal of Thoracic and Cardiovascular Surgery ● Janua21 patients with complete data at all time points through 5
years (Table 3). These results paralleled those achieved in
the overall cohort, with significant improvements in FEV1
and SMWT for more than 36 months and in RV, MITT, and
SF-36 PF score for more than 60 months.
Risk Analysis for Contralateral LVR and Survival
At 3 and 5 years, 80% and 70% of the patients, respectively,
were still free from contralateral treatment (Figure 3, A). At
the time of contralateral LVR, 6 patients’ FEV1 values had
returned to baseline, 4 patients still showed a change in
FEV1 between 0.1 and 0.17 L, and the other 4 patients still
showed a change in FEV1 between 0.2 and 0.24 L. At most
recent follow-up, 12 patients have died of the following
causes: respiratory failure (n  5), cancer-related causes (n
 5), and cardiac causes (n  2). The Kaplan-Meier esti-
mates of survival at 60 months and as late as 80 months are
shown in Figure 3, B.
Discussion
Since the pioneering work of Cooper and colleagues,9
who proposed simultaneous staple LVR through a me-
dian sternotomy, surgically oriented visual scoring sys-
tems for radiologic morphologic characteristics of em-
physema have been developed to help select candidates
for LVR.19-21 Results from CT-based qualitative morpho-
logic analyses have shown that distinct heterogeneity of
emphysema within the lung, with upper-lobe predomi-
nance of disease, is the main predictor of maximal benefit
after bilateral LVR.
Our thoracoscopic LVR program started more than 7
years ago, and the surgical strategy that we have since
applied was based on some arbitrary and unconventional
choices. Unilateral LVR was performed intentionally in
Postoperative
86) 1 y (n  69) 3 y (n  40) 5 y (n  21)
1.38) 1.10* (0.97-1.40) 1.03* (0.81-1.31) 0.94 (0.63-1.22)
) 39* (33-47) 35* (28-43) 32 (22-41)
3.25) 3.0* (2.45-3.23) 2.9* (2.4-3.12) 2.80 (2.44-3.06)
) 83* (64-91) 80* (64-87) 77 (62-84)
.5) 4.1* (3.7-4.6) 4.4* (4.0-4.7) 4.7† (4.5-4.9)
00) 175* (156-204) 187* (174-221) 205† (192-238)
) 72 (69-77) 69 (66-75) 68‡ (65-72.5)
20) 470* (450-520) 450* (425-485) 440 (380-470)
.5) 2.0* (1.5-2.5) 1.5* (1.0-2.0) 1.0‡ (0.5-2.0)
) 50* (50-70) 50* (45-60) 42.5‡ (27.5-50)hort
(n 
0.98-
34-48
2.46-
68-91
3.5-4
152-2
68-77
430-5
1.0-2
45-70patients with distinct heterogeneity of emphysema between
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classification, whereas simultaneous bilateral LVR was pre-
ferred in patients with heterogeneous disease within each
lung but symmetrically distributed between the lungs.
Initial series on unilateral thoracoscopic LVR resulted in
significant improvements in FEV1, RV, dyspnea indices,
and SMWT for as long as 12 months.5-8 However, these
early results were paralleled by those of McKenna and
coworkers,11 who reported significantly greater improve-
ments in measured spirometry and more frequent relief from
oxygen dependence after bilateral LVR than after unilateral
treatment. After that report, most surgical investigators
switched to the single-stage bilateral approach. Subsequent
studies have shown contradictory results, with some sur-
geons reporting incremental improvements in FEV1, PaO2,
dyspnea relief, SMWT, quality of life, and even survival
comparable to those of the bilateral treatment.7,8,13,14
The main finding of our study was that postoperative
improvements in respiratory function measures, maximal
and submaximal exercise capacity tests, and SF-36 quality
of life domain scores occurred early after unilateral LVR
and lasted more than 36 months. Improvements in SF-36 PF
score, RV, and MITT lasted for as long as 60 months. The
analysis of relationships between radiologic morphologic
factors and change in FEV1 demonstrated the existence of a
direct correlation between ARE and change in FEV1 at 36
months, which suggests that for these patients the higher the
ARE, the greater the change in FEV1. An other striking
feature is that at 60 months 70% of survivors were still free
from contralateral treatment. This suggests that in selected
cases unilateral LVR can offer long-lasting benefits, allow-
ing postponement of contralateral treatment for several
years.
Acute incremental improvements after unilateral LVR
largely exceeded half of those reported on average with
bilateral treatment. Becker and associates22 measured indi-
vidual lung volumes by volumetric CT analysis and showed
TABLE 3. Changes in outcome measures for 21 patients w
Baseline
(n  97) 6 mo (n  86)
FEV1 (L) 0.88 (0.73-1.10) 1.29* (1.10-1.58)
FEV1 (% predicted) 32 (27-40) 43* (39-58)
RV (L) 5.0 (4.8-5.5) 4.0* (3.8-4.4)
RV (% predicted) 222 (206-243) 187* (161-200)
SMWT (m) 400 (360-420) 500* (460-530)
MITT (Bruce class) 1.0 (0.50-1.0) 2.0* (1.5-2.5)
SF-36 PF score 30 (25-40) 65* (50-70)
Data are expressed as median values with interquartile ranges.
*P  .0002 versus baseline.
†P  .003 versus baseline.
‡P  .01 versus baseline.that unilateral LVR led to an increase in lung volume in the
The Journal of Thoracunoperated lung at total lung capacity. A possible explana-
tion is that, because of an interdependence between the
lungs, unilateral LVR improves the function of both lungs.
The SF-36 questionnaire has been widely used to inves-
tigate the effect of LVR on quality of life, and significant
improvements in SF-36 domains have been reported for as
long as 60 months, mostly after bilateral treatment.3 In our
series, many SF-36 domains improved significantly for as
long as 48 months, and PF remained improved at 60 months
in 57% of the patients. An almost identical figure was
recently reported by Yusen and colleagues,23 who found
significant clinical changes in PF at 6 months, 3 years, and
5 years in 90%, 69%, and 57% of patients after bilateral
LVR, respectively.
Recent results from the National Emphysema Treatment
Trial have shown that 3-year survival in patients with upper-
lobe prevailing emphysema and low baseline exercise ca-
pacity was significantly better after surgery than in the
medical arm (81% vs 66%).4 In our series, 96% of patients
operated on had upper-lobe prevailing emphysema with
impaired exercise capacity, although in our analysis the
latter was assessed in a different way from the National
Emphysema Treatment Trial. Our 82% 5-year survival
compares favorably with both the 69% 3-year survival after
unilateral LVR reported by Naunheim and colleagues16 and
the 72.6% 2-year survival after unilateral LVR reported by
Serna and colleagues.24 This difference may be due to the
inclusion of some patients who underwent a staged bilateral
LVR and thus could be the most unfit after only unilateral
treatment. However, it is worth noting that we found no
difference in survival between patients treated with unilat-
eral and staged bilateral LVR (data not shown). One limi-
tation of our study is that we had no routine preoperative
rehabilitation program. Rehabilitation is useful to stabilize
the clinical condition of the patient and to confirm the
decision for surgical intervention. This treatment modality
has no effect on respiratory function but can significantly
omplete data
Postoperative
1 y (n  69) 3 y (n  40) 5 y (n  21)
1.25* (1.02-1.40) 1.07* (0.85-1.24) 0.94 (0.63-1.22)
42* (37-52) 37* (29-46) 32 (22-41)
4.1* (3.8-4.4) 4.4* (4.1-4.7) 4.7† (4.5-4.9)
185* (168-205) 195* (181-221) 206† (192-237)
510* (450-550) 470* (440-500) 440 (380-470)
2.5* (2.0-3.0) 1.5* (1.0-2.5) 1.0‡ (0.5-2.0)
60* (50-70) 50* (45-60) 42.5‡ (27.5-50)ith cimprove exercise tolerance, subjective dyspnea, and quality
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have denied many patients some improvements with a po-
tentially increased operative risk. However, we performed
rehabilitation in 13 patients considered at increased opera-
tive risk, and the extremely low 90-day mortality rate of this
series, at the lower end of the range of 0%10 to 28%26
reported in other studies, is encouraging. Finally, the finding
that the benefit of rehabilitation is progressively lost within
the next 6 months25 could also bias the outcome assessment
by subtracting presurgical improvements during the early
Figure 3. A, Kaplan-Meier curve showing freedom from contralat-
eral LVR. Censored patients at 36 and 60 months were 46 and 26,
respectively. B, Kaplan-Meier survival graph showing predicted
survival. Censored patients at baseline, 36, 60, and 80 months
were 97, 46, 26, and 10, respectively.postoperative period.
78 The Journal of Thoracic and Cardiovascular Surgery ● JanuaOur study confirms and extends previous findings indi-
cating that radiologic morphologic character of emphysema
plays a key role in the selection of candidates for LVR.
Visual scoring systems are less precise than objective quan-
titative analysis and are subject to some interobserver dis-
agreement. On the other hand, visual scoring systems are
simpler and quicker to apply than quantitative analyses and
have already proved reliable in selecting candidates for
bilateral LVR.4 Moreover, with our own visual scoring
classification we had already achieved a satisfactory inter-
observer agreement, with intraclass correlations of 0.95 for
the emphysema severity parameter and 0.88 for the ARE.15
Lung perfusion scintigraphy also has been used to eval-
uate candidates for LVR and provides functional informa-
tion that can be complementary rather than redundant to
anatomic imaging studies.27 However, when applying a
visual semiquantitative scoring system of visual assessment
of perfusion scintigrams, correlation between scores of per-
fusion heterogeneity and functional outcome has been
weak.28
We believed that to help select candidates for unilateral
LVR, CT-based estimation of degree of emphysema heter-
ogeneity and regional hyperinflation is more useful than
scintigraphic estimation of degree of perfusion heterogene-
ity. Our data confirm that our simple and reproducible visual
scoring system readily and quite frequently demonstrates
marked heterogeneity of emphysema between the lungs
(ARE).
In conclusion, satisfactory long-term survival and signif-
icant improvements in respiratory function measures, exer-
cise capacity, and health-related quality of life domain
scores were seen as late as 60 months in a stringently
selected cohort of patients with distinct heterogeneity of
emphysema between the lungs undergoing intentional uni-
lateral LVR. These data must be interpreted with caution,
and not assumed to mean that one side is better than two.
Instead, it seems reasonable to hypothesize that suitable
candidates for either unilateral or bilateral LVR can be
discriminated by applying simple visual scoring systems
that are based on the radiologic morphologic character of
emphysema. Further investigation is warranted to eventu-
ally confirm, implement, or contradict our findings.
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